Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke: a 2×2 Factorial Randomized Controlled Trial (IMPACT)

NCT07252544 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT07252544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07252544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke: a 2×2 Factorial Randomized Controlled Trial (IMPACT)
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
February 29, 2028
Enrollment
3,156 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel diseases, stroke, acute ischemic, stroke, lacunar